Back to Journals » Clinical Ophthalmology » Volume 4

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity

Authors Velez-Montoya R, Clapp C, Rivera JC, Garcia-Aguirre G, Morales-Canton V, Fromow-Guerra, Guerrero-Naranjo JL, Quiros-Mercado H

Published 24 August 2010 Volume 2010:4 Pages 947—953


Review by Single-blind

Peer reviewer comments 3

Raul Velez-Montoya1, Carmen Clapp2, Jose Carlos Rivera2, Gerardo Garcia-Aguirre1, Virgilio Morales-Cantón1, Jans Fromow-Guerra1, Jose Luis Guerrero-Naranjo1, Hugo Quiroz-Mercado3

1Retina Department Asociación para Evitar la Ceguera en México IAP, México City, México; 2Department of Cellular and Molecular Neurobiology, Universidad Nacional Autónoma de México, Querétaro, México; 3Department of Ophthalmology, Denver Health Medical Center, University of Colorado School of Medicine, Colorado, USA

Purpose: To measure vitreous, aqueous, subretinal fluid and plasma levels of vascular ­endothelial growth factor in late stages of retinopathy of prematurity.

Methods: Interventional study. We enrolled patients with clinical diagnoses of bilateral stage V retinopathy of prematurity, confirmed by b-scan ultrasound and programmed for vitrectomy. During surgery we took samples from blood, aqueous, vitreous, and subretinal fluids. The vascular endothelial growth factor concentration in each sample was measured by ELISA reaction. A control sample of aqueous, vitreous and blood was taken from patients with congenital cataract programmed for phacoemulsification. For statistical analysis, a Mann–Whitney and a Wilcoxon W test was done with a significant P value of 0.05.

Results: We took samples of 16 consecutive patients who met the inclusion criteria. The vascular endothelial growth factor levels in the study group were: aqueous, 76.81 ± 61.89 pg/mL; vitreous, 118.53 ± 65.87 pg/mL; subretinal fluid, 1636.58 ± 356.47 pg/mL; and plasma, 74.64 ± 43.94 pg/mL. There was a statistical difference between the study and the control group (P < 0.001) in the aqueous and vitreous samples.

Conclusion: Stage 5 retinopathy of prematurity has elevated intraocular levels of vascular endothelial growth factor, which remains high despite severe retinal lesion. There was no ­statistical difference in plasma levels of the molecule between the control and study group.

Keywords: VEGF, late stages, ROP

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other articles by this author:

Long-term follow-up of patients with choroidal neovascularization due to angioid streaks

Martinez-Serrano MG, Rodriguez-Reyes A, Guerrero-Naranjo JL, Salcedo-Villanueva G, Fromow-Guerra J, García-Aguirre G, Morales-Canton V, Velez-Montoya R

Clinical Ophthalmology 2017, 11:23-30

Published Date: 19 December 2016

Difference in ocular surface temperature by infrared thermography in phakic and pseudophakic patients

Sniegowski M, Erlanger M, Velez-Montoya R, Olson JL

Clinical Ophthalmology 2015, 9:461-466

Published Date: 9 March 2015

Acute sterile endophthalmitis following intravitreal bevacizumab: case series

Orozco-Hernández A, Ortega-Larrocea X, Sánchez-Bermúdez G, García-Aguirre G, Morales Canton V, Velez-Montoya R

Clinical Ophthalmology 2014, 8:1793-1799

Published Date: 9 September 2014

Ocular argyrosis secondary to long-term ingestion of silver nitrate salts

Stafeeva K, Erlanger M, Velez-Montoya R, Olson JL

Clinical Ophthalmology 2012, 6:2033-2036

Published Date: 5 December 2012

Perfluorocarbon-perfused 23 gauge three-dimensional vitrectomy for complicated diabetic tractional retinal detachment

Velez-Montoya R, Guerrero-Naranjo JL, Garcia-Aguirre G, Morales-Cantón V, Fromow-Guerra J, Quiroz-Mercado H

Clinical Ophthalmology 2011, 5:1709-1715

Published Date: 20 December 2011

Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy

Grimelda Yuriana Sánchez-Castro, Alejandra Hitos-Fájer, Erick Mendoza-Schuster, Raul Velez-Montoya, Cecilio Francisco Velasco-Barona

Clinical Ophthalmology 2008, 2:657-660

Published Date: 12 September 2008

Readers of this article also read:

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010